Veracyte Says Data Supporting Use of Percepta Bronchial Genomic Classifier to Be Presented at CHEST 2015

By: via Benzinga
Veracyte, Inc. (NASDAQ: VCYT) announced that data assessing the clinical utility and performance of the company's genomic test to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.